Zhejiang Wecome Pharmaceutical Company Limited

SZSE:300878.SZ

23.26 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 96.177199.95387.619115.563120.7195.73956.942178.726111.839183.784131.541169.582199.57132.26150.375165.856183.782122.755187.511153.496150.397150.397
Kosten van de omzet 47.09102.12876.94740.14934.473106.19546.83657.91526.93888.40970.09739.2550.24844.78144.74844.96447.17234.53648.74239.56239.73139.731
Brutowinst 49.08897.82510.67375.41486.22789.54410.106120.81184.90195.37661.444130.332149.32287.479105.627120.892136.6188.219138.769113.934110.666110.666
Brutowinstmarge 0.510.4890.1220.6530.7140.4570.1770.6760.7590.5190.4670.7690.7480.6610.7020.7290.7430.7190.740.7420.7360.736
Onderzoek- en ontwikkelingskosten 3.2482.97122.9323.3827.6428.84211.25310.21610.0437.80821.4276.3175.1794.0927.7235.4391.3465.9015.9215.6054.8174.817
Algemene en administratieve kosten -7.43210.774-20.4424.762-4.7148.605-20.78925.187-6.248.77-11.32614.911-2.1255.016-9.1476.7166.8057.517-25.4375.5266.0026.002
Verkoop- en marketingkosten 53.31552.33784.61839.88843.66240.01848.8948.78636.90557.06343.12381.56390.67154.63256.61173.92782.32755.21575.2675.15370.69270.692
Verkoop-, algemene en administratieve kosten 58.32563.11164.17964.6538.94848.62328.173.97330.66565.83331.79796.47488.54659.64847.46480.64389.13262.73149.82380.67977.60177.601
Overige kosten -0.058-0.2830.336-4.579-0.122-0.407-1.694-0.053-0.0470.093-0.0273.028-2.2230.108-5.1310.3690.013-0.8970.4450.05700
Bedrijfskosten 61.6368.629116.33951.52160.19556.40561.18672.15843.573.52172.11795.11793.73663.33255.81482.3682.4968.84186.70884.67877.04877.048
Bedrijfsresultaat -12.54226.634-95.2120.30340.85433.039-53.44246.84439.8426.209-11.09836.46450.0923.68651.72137.77750.50519.03650.83229.38933.69933.699
Bedrijfsresultaat ratio -0.130.133-1.0870.1760.3380.169-0.9390.2620.3560.143-0.0840.2150.2510.1790.3440.2280.2750.1550.2710.1910.2240.224
Totaal overige inkomsten en kosten netto 2.289-0.2830.336-4.579-0.122-0.407-1.694-0.053-0.0470.093-0.0270.4360.3690.1080.1780.3690.013-0.8970.4990.057-0.268-0.268
Inkomen voor belasting -10.25326.351-94.87415.72540.73232.632-55.13646.79139.79426.302-11.12536.950.45923.79451.89838.14650.51818.1451.33129.44633.43133.431
Inkomen voor belasting ratio -0.1070.132-1.0830.1360.3370.167-0.9680.2620.3560.143-0.0850.2180.2530.180.3450.230.2750.1480.2740.1920.2220.222
Belastingkosten -1.8441.962-17.81710.3773.2244.614-5.6139.6695.4013.173-14.9067.6877.2783.4225.4916.8938.2052.4078.862.8714.9484.948
Nettowinst -10.14324.335-77.3894.7337.09527.526-49.48736.94534.06622.923.77728.94743.49820.27346.51831.25342.31315.73242.47226.57528.48328.483
Nettowinstmarge -0.1050.122-0.8830.0410.3070.141-0.8690.2070.3050.1250.0290.1710.2180.1530.3090.1880.230.1280.2270.1730.1890.189
WPA (Winst Per Aandeel) -0.0710.17-0.630.0330.260.19-0.340.260.240.280.0270.360.650.140.980.220.390.140.390.240.260.26
Verwaterde WPA -0.0710.17-0.630.0330.260.19-0.340.260.240.280.0270.360.650.140.980.220.390.140.390.240.260.26
EBITDA 2.22230.444-97.6720.25227.04738.752-42.2448.23540.84924.415-9.02439.68154.26525.69553.58839.95454.56818.95154.18429.52535.25635.256
EBITDA ratio 0.0230.152-1.1150.1750.2240.198-0.7420.270.3650.133-0.0690.2340.2720.1940.3560.2410.2970.1540.2890.1920.2340.234